罕见的病例报告显示,莫西弗洛克萨引起的持续性打
Jing Zhou1, Fei Wang2, Songlong Li3
1Department of Pharmacy, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
概括
这份病例报告详细介绍了一例罕见的持续性打病例,该病例发生在一名因结核性肺炎而接受莫西弗洛克萨治疗的患者身上. 甲托克洛普拉米德 (metoclopramide) 给药后子消失了,突出显示了潜在的不良药物反应.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 药物不良反应 药物不良反应
背景情况:
- 莫西弗洛克萨是一种广泛使用的宽谱抗生素.
- 持续的打会显著影响患者的舒适度和睡眠.
- 识别药物诱导的副作用对于患者的安全至关重要.
研究的目的:
- 报告与莫克西弗洛克萨使用相关的第一个已知的持续性打病例.
- 为了调查莫西弗洛克萨辛与打之间的潜在因果关系.
- 提高对这种罕见药物不良反应的临床意识.
主要方法:
- 一个40多岁的男性患者的案例研究,他因结核性肺炎而接受莫西弗洛克萨治疗.
- 临床评估以排除其他原因导致打.
- 纳兰乔尺度用于评估药物不良反应的因果关系.
- 用于管理打的美托克洛普拉米德的管理.
主要成果:
- 患者经历了持续的打,从莫西弗洛克萨辛注射后2小时开始.
- 打在第二天再次出现,扰乱了睡眠.
- 纳兰乔尺度表明莫西弗洛克萨辛与打之间可能存在关联 (得分为6).
- 打在服用梅托克洛普拉米德后2分钟内就停止了.
结论:
- 莫西弗洛克萨辛可能会导致持续的打作为一种罕见的药物不良反应.
- 这是第一个报告的莫西弗洛克萨辛诱导的打病例.
- 临床医生应考虑莫西弗洛克萨作为患者持续性抽的潜在原因.
相关概念视频
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
352
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
352
Esophageal Perforation-II: Clinical Manifestations and Management
94
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
94
Upper Respiratory Drugs: First and Second-Generation Antihistamines
338
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
338
Chronic Pharyngitis
3.0K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
3.0K
Antiasthma Drugs: Methylxanthines
278
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
278
Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217


